title: Telaprevir therapy, renal impairment, and their effects on the pharmacokinetics of tenofovir in HIV/hepatitis C virus coinfected patients.
authors.affiliation: a3rd Division of Infectious Diseases bUnit of Clinical Pharmacology, Luigi Sacco University Hospital, Milan, Italy.
authors.forename: Cristina
authors.initials: C
authors.lastname: Gervasoni
authors.forename: Laura
authors.initials: L
authors.lastname: Milazzo
authors.forename: Diletta
authors.initials: D
authors.lastname: Pezzani
authors.forename: Serena
authors.initials: S
authors.lastname: Fucile
authors.forename: Dario
authors.initials: D
authors.lastname: Cattaneo
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics*; D015658:HIV Infections / Q000188:drug therapy*; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced*; D008297:Male; D009842:Oligopeptides / Q000008:administration & dosage / Q000009:adverse effects*; D063065:Organophosphonates / Q000493:pharmacokinetics*; D000068698:Tenofovir
chemical_list: D000998:Antiviral Agents; D009842:Oligopeptides; D063065:Organophosphonates; C486464:telaprevir; D000068698:Tenofovir; D000225:Adenine